SR One / MP Healthcare Venture Management / Aescap Venture / TVM Capital / Beta Ltd. / Alpha Ltd. / Atlas Venture / Novo Ventures / Boehringer Ingelheim / Merck Serono Ventures / Bristol-Myers Squibb / /
Country
United States / United Kingdom / / /
Event
Funding / FDA Phase / M&A / /
IndustryTerm
therapies for breast cancer / biopharmaceutical / manufacturing / bispecific antibody products / /
MedicalCondition
breast and gastric cancer / cancer / HER2-positive solid tumours / certain HER2-positive cancers / gastric and colorectal cancer / HER2-positive cancers / tumour / breast and gastric cancer cambridge / HER2 positive tumours / breast cancer / tumours / /
F-star Announces Initiation of a Phase 1 Clinical Trial for FS102 for the Treatment of HER2-Positive Breast and Gastric Cancer CAMBRIDGE, UK – 9 JanuaryF-star, a biopharmaceutical company focused on oncology and